Exagen Inc — Balance Sheet (NASDAQ:XGN) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Total assets 78.38 M123.44 M86.22 M56.94 M44.69 M58.02 M Total liabilities 36.54 M38.51 M43.76 M34.25 M35.15 M40.57 M Total equity 41.84 M84.94 M42.46 M22.69 M9.54 M17.45 M Total liabilities & shareholders' equities 78.38 M123.44 M86.22 M56.94 M44.69 M58.02 M Total debt 26.66 M27.48 M29.67 M19.98 M20.45 M24.04 M Net debt -30.79 M-71.96 M-32.72 M-16.51 M-1.59 M-8.18 M

Nouvelles

KeyBanc cuts Exagen stock price target on pricing headwinds

Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11

L’objectif de cours d’Exagen abaissé à 10$ par Canaccord sur les perspectives de marge

Exagen stock price target lowered to $10 by Canaccord on margin outlook

BTIG abaisse l’objectif de cours d’Exagen à 9$ sur fond de prévisions de revenus réduites

BTIG cuts Exagen stock price target to $9 on lower revenue outlook

Exagen conserve sa note de surperformance chez William Blair

Exagen stock maintains Outperform rating at William Blair

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates

Le BPA de Exagen a manqué les attentes de 0,01$, le CA en dessous des prévisions

Exagen earnings missed by $0.01, revenue fell short of estimates

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates